Nestmedic Spolka Akcyjna

Major Shareholding Notification • May 4, 2022

Germany, issued on 29th of April 2022

Deutsche Balaton Aktiengesellschaft acting on behalf and with authority of Mr. Wilhelm K.T. Zours Germany (hereinafter: 'the Shareholder')

NESTMEDIC S.A.

ul. Pasymska 20 01-993 Warszawa Polska via e-mail: ir@nestmedic.com

Komisja Nadzoru Finansowego ul. Piękna 20 00-549 Warszawa Polska skr. poczt. 419 via e-mail: znaczne.pakiety@knf.gov.pl

Notification

Pursuant to the provisions of Article 69a of the Act on Public Offering, Conditions Governing the lntroduction of Financial lnstruments to Organised Trading, and Public Companies dated on July 29th 2005

Acting on behalf and with authority of Mr. Wilhelm K.T. Zours, 69120 Heidelberg, Germany (hereinafter referred to as "lndirect Shareholder") and in performing the obligation specified in Article 69a of the Act on Public Offering, Conditions Governing the lntroduction of Financial lnstruments to Organised Trading, and Public Companies (Journal of Laws of 2021, item 1983, as amended, hereinafter: 'Act on Public Offering') and in connection with the increase of the share capital of Nestmedic SA with registered office in Warsaw, (hereinafter: 'the Company') by the District Court in Warsaw for Warsaw, XIV National Court Register Division, dated on April 27, 2022, reported by the Company via EBI Report no. 10/2022 dated on April 28, 2022, acting on behalf of lndirect Shareholder I hereby notify that as a result of issuance and subscription of 3,760,000 M series shares by the Deutsche Balaton Aktiengesellschaft (hereinafter referred to as "Shareholder") the share of the lndirect Shareholder in the share capital and the total voting rights have changed.

1) The date and type of the event that leads to a change in the shareholding to which the notification relates:

Registration by the District Court in Warsaw for Warsaw, XIV National Court Register Division on April 27, 2022 the share capital increase of the Company in connection with the issuance and subscription of 3,760,000 M series shares by the Shareholder (total amount of the M series shares was 7,936,000 shares but the Shareholder took up 3,760,000 M series shares and 4,176,000 M series shares were taken up by other investors).

2) The number of shares held prior to the change in the shareholding and the proportion of the Company's share capital represented by those shares, as well as the number of votes attached to those shares and the proportion of the voting rights held:

Before the release of 3,760,000 series M shares of the Company to which the Shareholder subscribed and before the increase of the share capital of the Company, the Indirect Shareholder held 3,528,220 shares of the Company, representing approximately 26.08% of share capital of the Company and entitling to 3,528,220 votes at the General Meeting of Shareholders of the Company, representing approximately 26.08% of share in the total number of votes, indirectly through the Shareholder.

3) The current number of shares held and the proportion of the Company's share capital represented by those shares, as well as the number of votes attached to those shares and the proportion of the voting rights held:

After the registration of the share capital increase and subscription of 3,760,000 M series shares the Indirect Shareholder holds through the Shareholder 7,288,220 shares of the Company, representing approximately 33.96% of the share capital of the Company, entitling him to 7,288,220 votes at the General Meeting of Shareholders of the Company, representing approximately 33.96% of the total number of votes.

4) Subsidiaries of the Shareholder that makes the notification, which hold the Company's shares:

(a) The Indirect Shareholder – Wilhelm K.T. Zours is the major shareholder of DELPHI Unternehmensberatung Aktiengesellschaft;

(b) DELPHI Unternehmensberatung Aktiengesellschaft is the only shareholder of VV Beteiligungen Aktiengesellschaft;

(c) VV Beteiligungen Aktiengesellschaft is the major shareholder Deutsche Balaton Aktiengesellschaft, which holds directly 7,288,220 shares of the Company, representing approximately 33.96% of share capital and entitling him to 7,288,220 votes at the General Meeting of Shareholders of the Company.

5) The persons referred to in Article 87.1 (3) (c);

There are no persons mentioned in Art. 87.1 (3) (c) of Act on Public Offering.

6) - The number of votes from shares, calculated pursuant to Article 69b. 2, to whose acquisition they are entitled or obliged as a holder of financial instruments referred to in Article 69b.1 (1), as well as financial instruments referred to in Article 69b.1 (2) which are not exercised solely by cash settlement, the type and the name of those financial instruments, the date of their expiration, and about the date or time limit within which the acquisition of shares will or may occur:

The Indirect Shareholder does not hold the financial instruments referred to in Article 69b.1 (1) of Act on Public Offering.

In terms of the financial instruments referred to in Article 69b.1 (2) of Act on Public Offering:

• a) The number of votes from shares, calculated pursuant to Article 69b. 2, to which acquisition the Shareholder is entitled as a holder of financial instruments referred to in Article 69b.1 (2)
  • in terms of 28,571 Series A Bonds, number of votes may be 2,857,100,
  • in terms of 2,357,142 Series A Subscription Warrants, number of votes may be 2,357,142;
• b) The type of the financial instruments:
  • in terms of 28,571 Series A Bonds- bonds convertible into shares,
  • in terms of 2,357,142 Series A Subscription Warrants subscription warrants;
• c) The name of the financial instruments:
  • in terms of 28,571 Series A Bonds Series A Bonds;
  • in terms of 2,357,142 Series A Subscription Warrants Series A Subscription Warrants;
• d) The date of the expiration of financial instruments:
  • in terms of 28,571 Series A Bonds 3155 of July 2024;
  • in terms of 2,357,142 Series A Subscription Warrants 20th of September 2024;
• e} The time limit within which the acquisition of shares may occur:
  • in terms of 28,571 Series A Bonds from 20th of September 2019 to 31st of July 2024;
  • in terms of 2,357,142 Series A Subscription Warrants 20th of September 2019 to 20th of September 2024;
• 7) The number of votes from shares, calculated pursuant to Article 69b.3, to which the financial instruments referred to in art. 69b.1 (2) refer directly, the type and the name of these financial instruments, and about the date of their expiration:

Not applicable.

8) The total number of votes as indicated pursuant to subparagraph (3), (6), and (7) and its percentage share in the general number of votes.

As at the date of the notification, after conversion of 28,571 Series A Bonds into 2,857,100 Series G Shares of the Company and exercising the right of 2,357,142 Series A Subscription Warrants and in the result subscribing to 2,357,142 Series H Shares of the Company and respective increase of the share capital, the Indirect Shareholder may hold indirectly 12,502,462 shares of the Company, entitling to 12,502,462 votes, representing approximately 46.87% of share capital and entitling him to approximately 46.87% votes at the General Meeting of Shareholders of the Company.

The number of yotes and shares indicated above constitutes a forecast of the Indirect Shareholder's share held indirectly through the shareholder - in the event of exercising all the above-mentioned rights. In case of other than aforementioned changes in the Company's share capital, the Indirect Shareholder's share in the share capital of the Company and in the votes at the General Meeting of the Shareholders of the Company may change.

SIGNATURE

Alexander Link

Managing Director Deutsche Balaton AG acting on behalf and with authority of Mr. Wilhelm K.T. Zours

Notification is received by:

• 1) Nestmedic S.A.
• 2) Komisja Nadzoru Finansowego